Applied Data Research Analyzes Recent Advances and Healthcare Impact
(Nashua, NH) – Advances in molecular technologies are creating the potential for a new generation of imaging agents targeted to specific cells or microenvironments. These imaging agents will provide unique opportunities for studying normal and pathologic processes less invasively at the molecular and cellular level in vivo. Unlike many other sectors of the healthcare industry where technology successes periodical occur that seem to propel the market forward, these opportunities are being driven by the migratory advances of academic, public (government) and commercial research programs.
Current methods for noninvasive diagnostic imaging focus on anatomical and functional measurements. Molecular imaging is a growing research area aimed at developing and testing novel tools, reagents, and methods to image specific molecular pathways in vivo, particularly those that are key targets in disease processes. Molecular imaging probes the molecular abnormalities that are the basis of disease rather than imaging the result of molecular deviations.
One example of this trend is the development of targeted MRI probes, consisting of protein fragments capable of binding to cell surface receptors. Receptor-targeted probes that penetrate blood vessel walls easily are under investigation for solid-tumor diagnosis. This technology is the focus of development programs at several companies and academic laboratories. Other important molecular imaging technologies under investigation and clinical development include metabolic biomarkers, optical probes, nanoparticles, and activatable imaging agents.
These developments are examined in a new and comprehensive report - Molecular Imaging Agents: Evolving Capabilities, Emerging Opportunities. The report has been carefully researched and written to provide timely and insightful analysis of key factors and developments shaping this dynamic segment of the healthcare sector.
More information is available at www.applieddata.org .
About Applied Data
Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.
Contact:
Greg Stone
Voice: 603-595-6225
Fax: 603-804-0466
www.applieddata.org
Source: Applied Data Research
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
